Transient blood eosinophilia during treatment with Adalimumab

J Eur Acad Dermatol Venereol. 2012 Jul;26(7):924-5. doi: 10.1111/j.1468-3083.2011.04169.x. Epub 2011 Jul 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Eosinophilia / chemically induced*
  • Female
  • Humans
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab